APITOPE

apitope-logo

Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Gravesโ€™ disease, Factor VIII intolerance and uveitis. The company, whose first product candidate is licensed to Merck Serono, will now progress its remaining portfolio of product candidates developed with its proprietary platform technology.

#SimilarOrganizations #People #Financial #Website #More

APITOPE

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2002-01-01

Address:
Bristol, Bristol, City Of, United Kingdom

Country:
United Kingdom

Website Url:
http://www.apitope.com

Total Employee:
11+

Status:
Active

Total Funding:
22 M EUR

Technology used in webpage:
Person Schema Gravatar Profiles Gravity Forms British Server Location


Similar Organizations

aerogen-logo

Aerogen

Aerogen is a medical device and drug delivery company.

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

immunos-therapeutics-logo

ImmunOs Therapeutics

ImmunOs Therapeutics is a clinical-stage biotechnology company.

kbp-biosciences-logo

KBP Biosciences

A multinational clinical stage biotechnology company.

neumora-therapeutics-logo

Neumora Therapeutics

Neumora Therapeutics operates as a clinical-stage biotechnology company.

not_available_image

SA Biotech

SA Biotech is a Healthcare company.

Current Employees Featured

david-wraith_image

David Wraith
David Wraith Chief Scientific Officer & Founder @ Apitope
Chief Scientific Officer & Founder

keith-f-martin_image

Keith F Martin
Keith F Martin Chief Executive Officer @ Apitope
Chief Executive Officer

Founder


david-wraith_image

David Wraith

Investors List

limburgse-reconversie-maatschappij_image

Limburgse Reconversie Maatschappij

Limburgse Reconversie Maatschappij investment in Series B - Apitope

vesalius-biocapital-partners_image

Vesalius Biocapital Partners

Vesalius Biocapital Partners investment in Series B - Apitope

pmv-pharmaceutcals-inc_image

PMV Pharmaceuticals

PMV Pharmaceuticals investment in Series B - Apitope

wyvern-seed-fund_image

Wyvern Seed Fund

Wyvern Seed Fund investment in Series B - Apitope

arthurian-life_image

Arthurian Life Sciences

Arthurian Life Sciences investment in Series B - Apitope

vesalius-biocapital-partners_image

Vesalius Biocapital Partners

Vesalius Biocapital Partners investment in Series A - Apitope

vinnof_image

Vinnof

Vinnof investment in Series A - Apitope

Official Site Inspections

http://www.apitope.com

  • Host name: 176-58-126-104.ip.linodeusercontent.com
  • IP address: 176.58.126.104
  • Location: London United Kingdom
  • Latitude: 51.5164
  • Longitude: -0.093
  • Timezone: Europe/London
  • Postal: EC2V

Loading ...

More informations about "Apitope"

Apitope - Crunchbase Company Profile & Funding

Sep 29, 2015 Apitope is a European biotech company. Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic โ€ฆSee details»

Apitope Company Profile - Office Locations, Competitors ... - Craft

Apitope has 5 employees across 2 locations and $26.22 m in total funding,. See insights on Apitope including office locations, competitors, revenue, financials, executives, subsidiaries โ€ฆSee details»

Apitope - LinkedIn

Apitope | 1,510 followers on LinkedIn. Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis โ€ฆSee details»

Apitope International N.V. - Life-Sciences-Europe.com

Jan 13, 2009 Apitope is a clinical stage biotech company that develops potential first-in-class antigen-specific immunotherapies targeting autoimmune diseases.See details»

Apitope Company Profile 2024: Valuation, Investors, Acquisition

Information on acquisition, funding, cap tables, investors, and executives for Apitope. Use the PitchBook Platform to explore the full profile.See details»

Apitope - LinkedIn

Apitope | 1,511 followers on LinkedIn. Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis โ€ฆSee details»

Apitope - VentureRadar

"Apitope International NV is a biopharmaceutical company with its head office in Diepenbeek, Belgium, and a subsidiary in Bristol, United Kingdom.See details»

Apitope CEO and Key Executive Team | Craft.co

Apitope's Chief Executive Officer is Hayley French. Other executives include Stéphane Verdood, Non-Executive Director; Chairman of the Board; Liselotte Jansson, Chief Research Officer and โ€ฆSee details»

Apitope - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Sep 29, 2015: Series B - โ€ฆSee details»

Apitope International Company Profile | Diepenbeek, Belgium ...

Find company research, competitor information, contact details & financial data for Apitope International of Diepenbeek. Get the latest business insights from Dun & Bradstreet.See details»

Apitope - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Apitope is a European biotech company. Unlock even more features with Crunchbase ProSee details»

Apitope โ€“ World-leading clinical-stage biotech firm, developing โ€ฆ

October Edition 2020. Apitope โ€“ World-leading clinical-stage biotech firm, developing antigen-specific immunotherapeutics for autoimmune diseasesSee details»

Worg Pharma to Acquire Apitope - BioVille

Expands immunotherapy pipeline with potential first in class treatments for a range of autoimmune diseases. Hangzhou, China and Diepenbeek, Belgium, (August 18, 2021): Worg โ€ฆSee details»

Interview with Keith Martin, CEO, Apitope - pharmaboardroom.com

Apitopeโ€™s research and success is based on its High Speed Technology Platform that uses solubleโ€ฆSee details»

Apitope strengthens its board with new director - PMLiVE

Mar 22, 2018 Clinical stage biotech Apitope has appointed Dr William Jenkins as its independent, non-executive director to its board. Dr Jenkins has a wealth of pharmaceutical โ€ฆSee details»

Home - Epitopea

Epitopea is a transatlantic cancer immunotherapeutics company based in Montreal, Canada and Cambridge, UK. Our proprietary CryptoMap TM platform, created and optimized by Drs. โ€ฆSee details»

Worg Pharmaceuticals to Acquire Apitope International

Sep 29, 2021 Worg Pharmaceuticals to Acquire Apitope International Expands immunotherapy pipeline with potential first-in-class treatments for a range of autoimmune diseases Hangzhou, โ€ฆSee details»

Rope Access Services Melbourne | API Rope Access

API Rope Access offers a wide range of rope access services in Melbourne. From caulking and water testing to recladding, builders clean to facade repairs, we offer a comprehensive range โ€ฆSee details»

Epitopea - Crunchbase Company Profile & Funding

Epitopea is a transatlantic cancer immunotherapeutics company. Epitopea is a transatlantic biotechnology company developing transformational immunotherapies to treat cancer by โ€ฆSee details»

Rope Access Electrician | API Rope Access

Email: [email protected]. MICHELLE VASSALLO. Chief Finance Officer. Mobile: 0411 708 623 Email: [email protected]. Access Personnel International Pty Ltd is an industry leader in โ€ฆSee details»

linkstock.net © 2022. All rights reserved